Collegium Pharmaceutical (COLL) Non Operating Income (2014 - 2016)

Collegium Pharmaceutical's Non Operating Income history runs 3 years deep, the most recent figure standing at -$66000.0 for Q1 2016.

• On a quarterly basis, Non Operating Income rose 57.42% year-over-year to -$66000.0 in Q1 2016; TTM through Mar 2016 was -$351000.0, a 6.9% increase from a year earlier, with the FY2015 full-year figure at -$439000.0, down 74.21% from the prior year.
• Non Operating Income advanced to -$66000.0 in Q1 2016 per COLL's latest filing, from -$89000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at -$29000.0 in Q1 2014 and bottomed at -$155000.0 in Q1 2015.
• The 3-year median for Non Operating Income is -$89000.0 (2015), against an average of -$84111.1.
• Across the five-year window, Non Operating Income slumped 434.48% in 2015 and surged 57.42% in 2016, its largest moves.
• Year by year, Non Operating Income stood at -$142000.0 in 2014, then surged by 37.32% to -$89000.0 in 2015, then advanced by 25.84% to -$66000.0 in 2016.
• Per Business Quant, the three latest COLL Non Operating Income figures stand at -$66000.0 (Q1 2016), -$89000.0 (Q4 2015), and -$97000.0 (Q3 2015).